Steven Stein
Chief Tech/Sci/R&D Officer bij INCYTE CORPORATION
Vermogen: 6 M $ op 29-02-2024
Profiel
Steven H. Stein bekleedt de functie van Chief Medical Officer & Executive Vice President bij Incyte Corp. Dr. Stein zit ook in de raad van bestuur van Kura Oncology, Inc. In zijn vorige loopbaan was Dr. Stein Vice President-Global Oncology bij GlaxoSmithKline (New Jersey), SVP-US Clinical Development & Medical Affairs bij Novartis Oncology, Inc. en Senior VP-US Clinical Development & Medical Affair bij Novartis Pharmaceuticals Corp. Dr. Stein behaalde een doctoraat aan de Universiteit van de Witwatersrand.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
INCYTE CORPORATION
0.04% | 14-02-2024 | 97 595 ( 0.04% ) | 6 M $ | 29-02-2024 |
KURA ONCOLOGY, INC.
-.--% | 31-03-2023 | 0 ( -.--% ) | - $ | 29-02-2024 |
Actieve functies van Steven Stein
Bedrijven | Functie | Begin |
---|---|---|
INCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 02-03-2015 |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consultant / Advisor | - |
University of Pennsylvania | Corporate Officer/Principal | - |
Eerdere bekende functies van Steven Stein
Bedrijven | Functie | Einde |
---|---|---|
THESEUS PHARMACEUTICALS, INC. | Director/Board Member | 14-02-2024 |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01-02-2015 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01-02-2015 |
GlaxoSmithKline (New Jersey) | Corporate Officer/Principal | 01-04-2011 |
KURA ONCOLOGY, INC. | Director/Board Member | - |
Opleiding van Steven Stein
University of the Witwatersrand | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
INCYTE CORPORATION | Health Technology |
KURA ONCOLOGY, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
GlaxoSmithKline (New Jersey) | |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |